Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
54.19Prev. Close
54.14Volume
20,74,309Total traded value
11.03 CrUpper Circuit
64.96Lower Circuit
43.31Fundamentals
| Market Cap | ₹2,967Cr |
| ROE | 10.21% |
| P/E Ratio(TTM) | 32.04 |
| EPS(TTM) | 1.69 |
| P/B Ratio | 2.57 |
| Dividend Yield | 0.37% |
| Industry P/E | 35.77 |
| Book Value | 21.10 |
| Debt to Equity | 0.09 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Morepen Labs
For four decades, Morepen has been a symbol of excellence and innovation in the healthcare industry. On the completion of 4 glorious decades, the company upholds Excellence as its core value. Its vast array of products have been catering to the needs of over 100 million discerning consumers.;
| Parent Organisation | Morepen Laboratories Limited |
| Managing Director | Mr. Sushil Suri |
| NSE Symbol | MOREPENLAB |
Shareholding Pattern
Aug '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 104.06 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.19 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 34.19 | ||
| Wockhardt | NA (0.00%) | -198.91 |